Characteristics of bone turnover markers in rapidly destructive coxopathy
Tóm tắt
The purpose of this study was to clarify bone turnover marker levels in rapidly destructive coxopathy (RDC). Twenty patients with RDC (mean age, 72 ± 11 years; 3 men, 17 postmenopausal women), 111 with osteoarthritis (OA) (age, 60 ± 10 years; 15 men, 13 premenopausal women, 83 postmenopausal women), and 18 with osteonecrosis of femoral head (ON) (55 ± 14 years; 11 men, 3 premenopausal women, 4 postmenopausal women), and 100 patients with femoral neck fracture (FNF) (81 ± 10 years; 27 men, 73 postmenopausal women) were included. Serum tartrate-resistant acid phosphatase 5b (TRACP-5b), bone alkaline phosphatase (BAP), matrix metalloproteinase-3 (MMP-3) levels, and bone mineral density (BMD) of proximal femur and lumbar spine were investigated. TRACP-5b levels were significantly higher in RDC than in OA and ON, whereas BAP levels were higher in RDC than in OA (P < 0.05). MMP-3 levels were higher in RDC and ON than in OA (P < 0.05). TRACP-5b were higher in RDC than OA (P < 0.05) and FNF (P < 0.05) in performing propensity score matching; there were no differences in BMD between RDC and OA. TRACP-5b showed the largest area under the curve (AUC, 0.82) according to receiver operating characteristic (ROC) curve analysis for diagnosing RDC against OA and ON. AUCs of BAP and MMP-3 were 0.78 and 0.74. The respective sensitivities and specificities were 70.0 % and 85.3 % for TRACP-5b (cutoff, 623 mU/dl), 95.0 % and 57.1 % for BAP (13.8 U/l), and 70.0 % and 76.4 % for MMP-3 (52.7 ng/ml). The lack of differences in BMD suggested that high bone turnover marker levels may reflect osteoclast cell activation in RDC hips. Serum TRACP-5b and BAP could be RDC markers.
Tài liệu tham khảo
Postel M, Kerboull M (1970) Total prosthetic replacement in rapidly destructive arthrosis of the hip joint. Clin Orthop Relat Res 72:138–144
Watanabe W, Sato K, Itoi E, Yang K, Watanabe H (2002) Posterior pelvic tilt in patients with decreased lumbar lordosis decreases acetabular femoral head covering. Orthopedics 25:321–324
Masuhara K, Nakai T, Yamaguchi K, Yamasaki S, Sasaguri Y (2002) Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip. Arthritis Rheum 46:2625–2631
Ogawa K, Mawatari M, Komine M, Shigematsu M, Kitajima M, Kukita A, Hotokebuchi T (2007) Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis. J Bone Miner Metab 25:354–360
Li W, Sakai T, Nishii T, Nakamura N, Takao M, Yoshikawa H, Sugano N (2009) Distribution of TRAP-positive cells and expression of HIF-1alpha, VEGF, and FGF-2 in the reparative reaction in patients with osteonecrosis of the femoral head. J Orthop Res 27:694–700
Sabokbar A, Fujikawa Y, Neale S, Murray DW, Athanasou NA (1997) Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 56:414–420
Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA, IOF-IFCC Bone Marker Standards Working Group (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420
Michelsen J, Wallaschofski H, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, Hannemann A (2013) Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone (NY) 57:399–404
Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X (2013) Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients. Clin Chim Acta 426:102–107
Savarino L, Avnet S, Greco M, Giunti A, Baldini N (2010) Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: a cohort study. J Orthop Res 28:887–892
Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E (2003) Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis 62:939–943
Berger CE, Kröner A, Stiegler H, Leitha T, Engel A (2005) Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip. Int Orthop 29:1–5
Sugano N, Ohzono K, Nishii T, Sakai T, Haraguchi K, Yoshikawa H, Kubo T (2001) Early MRI findings of rapidly destructive coxopathy. Magn Reson Imaging 19:47–50
Sugano N, Kubo T, Takaoka K, Ohzono K, Hotokebuchi T, Matsumoto T, Igarashi H, Ninomiya S (1999) Diagnostic criteria for non-traumatic osteonecrosis of the femoral head. A multicentre study. J Bone Joint Surg Br 81:590–595
Ikemura S, Yamamoto T, Motomura G, Nakashima Y, Mawatari T, Iwamoto Y (2010) MRI evaluation of collapsed femoral heads in patients 60 years old or older: differentiation of subchondral insufficiency fracture from osteonecrosis of the femoral head. AJR Am J Roentgenol 195:W63–W68
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840
Yamaguchi R, Yamamoto T, Motomura G, Ikemura S, Iwasaki K, Zhao G, Doi T, Iwamoto Y (2014) Bone and cartilage metabolism markers in synovial fluid of the hip joint with secondary osteoarthritis. Rheumatology (Oxf) 53:2191–2195
Mountzios G, Ramfidis V, Terpos E, Syrigos KN (2011) Prognostic significance of bone markers in patients with lung cancer metastatic to the skeleton: a review of published data. Clin Lung Cancer 12:341–349
Iwase T, Hasegawa Y, Ishiguro N, Ito T, Iwasada S, Kitamura S, Iwata H (1988) Synovial fluid cartilage metabolism marker concentrations in osteonecrosis of the femoral head compared with osteoarthrosis of the hip. J Rheumatol 25:527–531
Watanabe W, Itoi E, Yamada S (2002) Early MRI findings of rapidly destructive coxarthrosis. Skelet Radiol 3:35–38
Niimi R, Hasegawa M, Sudo A, Uchida A (2005) Rapidly destructive coxopathy after subchondral insufficiency fracture of the femoral head. Arch Orthop Trauma Surg 125:410–413
Okano K, Aoyagi K, Enomoto H, Osaki M, Chiba K, Yamaguchi K (2014) Bone mineral density in patients with destructive arthrosis of the hip joint. J Bone Miner Metab 32:312–316
Richette P, Vicaut E, de Vernejoul MC, Orcel P, Bardin T (2009) Bone mineral density in patients with rapidly destructive or common hip osteoarthritis. Clin Exp Rheumatol 27:337–339